Clinical Trial Update: Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating venetoclax plus reduced-intensity conditioning allogeneic stem cell transplantation in elderly patients with high-risk myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myeloid Malignancy

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Xianmin Song, MD | Conditions: Leukemia, Myeloid, Acute, MDS | Phase 2 | Status: UNKNOWN